Evidio Domingo-Musibay – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailmusib024umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

7 Finished
7 Active

7 results

Filter

Finished
Immunomodulatory affects of radioembolization: a prospective study of peripheral monocyte modulation, immune cell infiltration, and cytokine variation.
Young, S. J., Domingo-Musibay, E., Golzarian, J. & Lou, E.
RADIOLOGICAL SOC OF NORTH AMERICA
7/1/20 → 6/30/22
Project: Research project
MMP-01: Pilot Study Evaluating Activity of the Combination of Anti-PD-1 Antibody with High Dose IL-2 in Metastatic Melanoma
Domingo-Musibay, E.
HOOSIER CANCER RESEARCH NETWORK, INC.
8/12/19 → 12/31/19
Project: Research project
Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
Domingo-Musibay, E.
BRISTOL-MYERS SQUIBB COMPANY
2/1/19 → 1/30/20
Project: Research project
A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OFNKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMABIN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES
Domingo-Musibay, E.
NEKTAR THERAPEUTICS
5/1/18 → 5/31/22
Project: Research project
CITN-09: A Phase II Study of MK-3475 in Patients with Ad
Domingo-Musibay, E.
Fred Hutchinson Cancer Research Center
9/1/16 → 4/11/17
Project: Research project
A Phase 1b/2, Open-label, Multicenter, Dose-escalation a
Domingo-Musibay, E.
DYNAVAX TECHNOLOGIES CORPORATION
9/1/16 → 11/30/18
Project: Research project
A US Multi-Site Observational Study in Patients with Unr
Domingo-Musibay, E.
BRISTOL-MYERS SQUIBB COMPANY
5/1/16 → 6/30/21
Project: Research project